Rani Therapeutics Holdings (RANI) Construction in Progress (2020 - 2021)
Rani Therapeutics Holdings' (RANI) quarterly Construction in Progress came in at $3.5 million in Q4 2021, little changed year-on-year from $3.5 million in Q4 2020, and little changed quarter-over-quarter from $3.5 million in Q4 2020.
Rani Therapeutics Holdings (RANI) Construction in Progress (2020 - 2021) Analysis & Trends
Rani Therapeutics Holdings' Construction in Progress history runs 2 years deep, the most recent figure standing at $3.5 million for Q4 2021.
- On a quarterly basis, Construction in Progress changed 0.0% year-over-year to $3.5 million in Q4 2021; TTM through Dec 2021 was $3.5 million, a 0.0% change from a year earlier, with the FY2021 full-year figure at $3.5 million, changed 0.0% from the prior year.
- Construction in Progress steadied at $3.5 million in Q4 2021 per RANI's latest filing, from $3.5 million in the prior quarter.
- Across five years, Construction in Progress topped out at $3.5 million in Q4 2020 and bottomed at $3.5 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 137.45 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Rani Therapeutics Holdings | 160.20 Mn | 167.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 3.50 Mn |
| Dec 31, 2020 | 3.50 Mn |